SIN_1016566 |
4 |
+
ATGGCTGATATGAAGAAAGGTGCCAGGGGAAGAGTGAAATGGGATGAAGA
TAACTTGGGGGAAATCGAGGCAACTAAACCCGTGAGGCAGAAAATAACTG
AACCGAAGACACCTTATCATCCAATGATTGATGATGAAGGATCATTATCT
CCTATTAGAAGCGGAAGTTTCGAAGATGGTTTGGAGGACGCAATGCATGC
AGAAGCCATCCGTTCAGCATTGAATGATGTAGCTTCCTCCAGCAAAACTA
ACTCGCATCAATCTGGCTGGAGTACATCTGAAGATGAGGCAGATGCAATG
GAACAAGATGGAGAAGGTTCCGACTTTGAGAGACACAGGAGCTTTAGGGA
GCACAGGAAAGCTCACTACGACGAGTTTCGCAAGGTCAAAGAACTTCTGC
GCCAGGGCTCCTTTCTTGAAGATGAGTCTGATGAGGAGACAAAGGCCAAT
GGTAAGAAAGACAGGCAATGTGTTTCATCGTCATCCATAACTGATGGTGC
GGAAGACATCGACGTTGAGAAACCATCAAAGCCAGCAAATGGATCTTAA
|
standard]
MADMKKGARGRVKWDEDNLGEIEATKPVRQKITEPKTPYHPMIDDEGSLS
PIRSGSFEDGLEDAMHAEAIRSALNDVASSSKTNSHQSGWSTSEDEADAM
EQDGEGSDFERHRSFREHRKAHYDEFRKVKELLRQGSFLEDESDEETKAN
GKKDRQCVSSSSITDGAEDIDVEKPSKPANGS
|
IPR007062; Protein phosphatase inhibitor 2 (IPP-2) |